COMMUNIQUÉS West-GlobeNewswire
-
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2026
29/06/2026 -
Résultats AGE - 29 juin 2026
29/06/2026 -
EssilorLuxottica: Déclaration de transactions sur actions propres
29/06/2026 -
BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round
29/06/2026 -
EssilorLuxottica: Disclosure of transactions in own shares
29/06/2026 -
EmblemHealth Sees 50% Increase in Member Adoption and Engagement Following Debut of Redesigned Mobile App
29/06/2026 -
Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector
29/06/2026 -
Achieve Life Sciences Joins Russell 2000® Index
29/06/2026 -
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
29/06/2026 -
SPR Wins Fifth Consecutive Northeast Ohio Top Workplaces Award
29/06/2026 -
New Video Series “Ahead of Alzheimer’s” Launches Focused on a Renewed Look at Early Alzheimer’s Detection and Preventive Brain Health Care
29/06/2026 -
Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
29/06/2026 -
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
29/06/2026 -
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
29/06/2026 -
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
29/06/2026 -
Tria Federal Earns Three Positions on NASA SEWP VI Government-Wide IT Contract
29/06/2026 -
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
29/06/2026 -
Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003
29/06/2026 -
Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026
29/06/2026
Pages